Dactoma^®

Dactinomycin

Product Information

Proprietary Name: Dactoma®
Generic Name: Dactinomycin
Dosage Form: Vial
Strengths: 0.5 mg
Indications: Wilms Tumor, Rhabdomyosarcoma, Ewing Sarcoma, Testicular Cancer, Gestational Trophoblastic Neoplasia, Solid Malignancies

Download Leaflet

Oncology

Dactoma®

Dactinomycin is indicated for the treatment of wilms tumor, rhabdomyosarcoma, ewing sarcoma, testicular cancer, gestational trophoblastic neoplasia, and solid malignancies.

Apply for a Job Position

Curious about job opportunities?

Signup for a job

Dactoma®

Product Information

Dactoma®

Apply for a Job Position

Products

Support

Company

Follow Us

Dactoma^®